Cite
APA Citation
Cunningham‐Bussel, A., Wang, J., Prisco, L. C., Martin, L. W., Vanni, K. M. M., Zaccardelli, A., Nasrallah, M., Gedmintas, L., MacFarlane, L. A., Shadick, N. A., Awad, M. M., Rahma, O., LeBoeuf, N. R., Gravallese, E. M., & Sparks, J. A. (2022). predictors of Rheumatic Immune‐Related Adverse Events and De Novo Inflammatory Arthritis After Immune Checkpoint Inhibitor Treatment for Cancer. Arthritis & rheumatology, 74(3), 527–540. http://access.bl.uk/ark:/81055/vdc_100152326660.0x00000a